Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

PharmaTech 2017

Sessions and Tracks

Conference Series LLC invites all the participants from all over the world to attend “International Conference and Exhibition on Pharmaceutical Development and Technology” during April 24-26, 2017 in Dubai, UAE.Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Pharma Tech 2017 is a latest technological platform to aid efficient drug discovery and development. These platforms range from vast chemical libraries, ultra-high throughput screening and huge genetic databases in discovery, to predictive toxicology platforms and even deep-seated knowledge of particular therapeutic areas in development. New research platforms designed to help its teams of investigators focus on a set of key strategic initiatives that will help guide their multibillion-dollar drug development program to advance new medicines that can get ahead of a disease and prevent it from taking a toll. Conferenceseries LLC organizes a conference. Series of 3000+ global events inclusive of 600+ Conferences, 1200+ Upcoming and Previous Symposiums and 1200+Workshops in USA, Europe & Asia with support from 1000 more scientific societies , 15 million unique visitors per year, 36 million page views per year. Publishes700+ Open access Journals which contains over 70000 eminent personalities, reputed scientists as editorial board members with 21 days rapid review process.

Track 01: Physical Pharmacy

In the past Physical pharmacy is associated with the area of pharmacy that deals with the quantitative and theoretical principles of science as they applied to the practice of pharmacy .But now a days physical pharmacy attempted to integrate the factual knowledge of pharmacy through the development of Broet principles .Pharmacist should have the knowledge about the compatibility, Stability and biological reaction of drug. Physical pharmacy is a branch of pharmaceutics to change the drugs from one state to other state, changes the action by physically with the applications of the theories.

Related Conference

7th Annual Global Pharma Summit, August 22-24, 2016 New Orleans, Louisiana, USA; 6th Pharmacovigilance Congress, September 28-30, 2016 Toronto, Canada ; Drug Formulation & Bioavailability Congress , September 05-07, 2016 Beijing, China ;18th International Conference on Pharmaceutical Pre-formulation and Clinical Drug Development, August 4th-5th,2016 Vancouver, Canada;  2016  AAPS Annual Meeting and Exposition, November 13th–17th, 2016, Denver, USA;International Pharmaceutical Federation (FIP); International Federation of Pharmaceutical Manufacturers and Associations (IFPMA); European Federation of Pharmaceutical Industries and Associations (efpia); Indian Pharmaceutical Association; American Association of Pharmaceutical Scientists (AAPS)

Track 02: Bio pharmaceutics & Pharmacokinetics

Bio pharmaceutics examines the interrelationship of the physical/chemical properties of the drug, the dosage form (drug product) in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption. The importance of the drug substance and the drug formulation on absorption, and in vivo distribution of the drug to the site of action, is described as a sequence of events that precede elicitation of a drug's therapeutic effect. Whereas Pharmacokinetics deals with the characteristic interactions of a drug and the body in terms of its absorption, distribution, metabolism, and excretion

First, the drug in its dosage form is taken by the patient either by an oral, intravenous, subcutaneous, transdermal, etc, route of administration. Next, the drug is released from the dosage form in a predictable and characterizable manner. Then, some fraction of the drug is absorbed from the site of administration into either the surrounding tissue, into the body (as with oral dosage forms), or both. Finally, the drug reaches the site of action. A pharmacologic response results when the drug concentration at the site of action reaches or exceeds the minimum effective concentration (MEC). The suggested dosing regimen, including starting dose, maintenance dose, dosage form, and dosing interval, is determined in clinical trials to provide the drug concentrations that are therapeutically effective in most patients. This sequence of events is profoundly affected—in fact, sometimes orchestrated—by the design of the dosage form and the physicochemical properties of the drug.

Related Conferences

2nd International Conference and Expo on Biopharmaceutics and Biologic Drugs ,San Antonio, Texas, USA; Amalgamating technology and innovation for developing consistent quality API’s, 25 -27 July, 2016 - The Westin, Mumbai  , September 14-16, 2016; LYOPHILISATION EUROPE, 4TH TO 5TH JULY 2016, ,LONDON,UK; Innovations in formulation and drug discovery,28-29th july,2016; Drug Formulation & Bioavailability Congress, September 05-07, 2016 Beijing, China; International Conference and Exhibition on Pharmaceutical Development and Technology, April 24-26, 2017 Dubai, UAE; Asia Pacific Drug Formulation & Bioavailability Congress, September 05-07, 2016, Beijing, China; International Pharmacy Conference, 14th - 15th July 2016, Pennsylvania, USA; 5th Global Pharmacists Annual Meeting, 14th - 16th July 2016, Brisbane, Australia; Asia Pacific Pharma Congress, 14th - 16th July 2016, Kuala Lumpur, Malaysia; 5th Annual European Pharma Congress, 18th - 20th July 2016; 10th International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care, 25th - 27th July 2016, Bangkok, Thailand; II International Conference on Clinical Sciences and Drug Discovery, 27th - 29th July 2016, Scotland, United Kingdom;Royal Pharmaceutical SocietyAmerican Pharmacists Association (APhA); American Society of Health-System Pharmacists (ASHP); National Pharmacy Association; Canadian Pharmacists Association; European Pharmaceutical Union (EPU)

Track 03: Formulation Development

Pharmaceutical Formulation is the process in which different chemical substances i.e., active chemical substances will combined together to produce a medical compound i.e., medical drug. This process involves production of drug which characterized by two things: first it must be a stable product, second it must be acceptable to the patient who will use it. Besides that in case of synthesis of an oral medication (tablet or capsule) it will contain a variety of ingredients besides the drug itself so it is an obligate matter to be sure that all of these ingredients must be incorporate with each other. Therefore it is very important to do a lot of formulation studies in order to detect the point of incorporation. Besides that formulation studies must focus on other factors like particle size, polymorphism, pH and solubility, in order to check whether these factors will effect on bioavailability of the drug or not.

There are two types or classifications for Pharmaceutical Formulation, these types are the following: Oral formulation- The most important characteristic for oral formulation it must be overcome the problems which associated with oral administration. The most critical problem is rate of drug solubility i.e., the active ingredient of the drug must be soluble in aqueous solution in a constant rate. This point can be controlled through some factors like particle size and crystal form. The oral formulation divided in two parts which are: Tablet form & Capsule form.  Topical medication forms- This type include several parts as the following: Cream,  Ointment, Gel,  Paste, and Powder.

Related Conferences

Drug Formulation & Bioavailability Congress, September 05-07, 2016 Beijing, China; International Conference and Exhibition on Pharmaceutical Development and Technology, April 24-26, 2017 Dubai, UAE; Asia Pacific Drug Formulation & Bioavailability Congress, September 05-07, 2016, Beijing, China; International Pharmacy Conference, 14th - 15th July 2016, Pennsylvania, USA; 5th Global Pharmacists Annual Meeting, 14th - 16th July 2016, Brisbane, Australia; Asia Pacific Pharma Congress, 14th - 16th July 2016, Kuala Lumpur, Malaysia; 5th Annual European Pharma Congress, 18th - 20th July 2016; 10th International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care, 25th - 27th July 2016, Bangkok, Thailand; II International Conference on Clinical Sciences and Drug Discovery, 27th - 29th July 2016, Scotland, United Kingdom; NANODDS-14th International Nano-medicine and Drug Delivery Symposium, John Hopkins University, September 16-18, 2016, Baltimore; 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2016,28th August  - 1st September 2016,Buenos Aires, Argentina; 6th Pharmaceutical Sciences World Congress (PSWC) 2017,21st  - 24th May 2017,Stockholm, Sweden; Royal Pharmaceutical Society Annual Conference 2016,International Convention Centre, 4th - 5th September 2016,Birmingham, UK; 11th International Conference and Expo on Nano-science and Molecular Nanotechnology, Crowne Plaza Heathrow, 26th - 28th September 2016, London, UK; International Conference on Nano-medicine and Nano-biotechnology 2016, Pierre and Marie Curie University, 28th - 30th September 2016,Paris, France.Pharmaceutical Society Of New ZealandChinese Pharmaceutical AssociationPakistan Pharmacists AssociationInternational Pharmaceutical Federation (FIP); International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)

Track 04: Optimization Techniques in Pharmaceutical Formulation and Processing

The term Optimize is defined as “to make perfect”. It is used in pharmacy relative to formulation and processing. It is involved in formulating drug products in various forms. It is the process of finding the best way of using the existing resources while taking in to the account of all the factors that influences decisions in any experiment. Final product not only meets the requirements from the bio-availability but also from the practical mass production criteria It helps the pharmaceutical scientist to understand theoretical formulation and the target processing parameters which ranges for each excipients &processing factors In development projects, one generally experiments by a series of logical steps, carefully controlling the variables & changing one at a time, until a satisfactory system is obtained. It is not a screening technique.

Related Conferences

Drug Formulation & Bioavailability Congress, September 05-07, 2016 Beijing, China; RICT 2016 — Interfacing Chemical Biology and Drug Discovery, 06-09 Jul 2016, Caen, France; International Conference and Exhibition on Pharmaceutical Development and Technology, April 24-26, 2017 Dubai, UAE; Asia Pacific Drug Formulation & Bioavailability Congress, September 05-07, 2016, Beijing, China; International Pharmacy Conference, 14th - 15th July 2016, Pennsylvania, USA; 5th Global Pharmacists Annual Meeting, 14th - 16th July 2016, Brisbane, Australia; Asia Pacific Pharma Congress, 14th - 16th July 2016, Kuala Lumpur, Malaysia; 5th Annual European Pharma Congress, 18th - 20th July 2016; 10th International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care, 25th - 27th July 2016, Bangkok, Thailand; II International Conference on Clinical Sciences and Drug Discovery, 27th - 29th July 2016, Scotland, United Kingdom; 3rd Annual Advanced API Convention, 25 Jul 2016 - 27 Jul 2016,India;  CSDD-2016 — II International Conference on Clinical Sciences and Drug Discovery, 27 - 29 Jul 2016, Scotland, United Kingdom; Innovations in Formulation and Drug Delivery 2016, 28 - 29 Jul 2016,India; Drug Discovery & Therapy World Congress 2016 (4th in the Series), 22 Aug 2016 - 25 Aug 2016, MA, United States; 2016 Pharma CI USA Conference & Exhibition, 13-14 Sep 2016, NJ, United States; 4th GPCR in Drug Discovery Conference, 14 - 15 Sep 2016, Boston, United States; DOT — 14th Annual Discovery on Target, 19 - 22 Sep 2016,Boston, MA, United States; 2nd Annual Quality in Pharma & Biotech, 22 - 23 Sep 2016, Vienna, Austria; 4th Symposium on Innovative Polymers for Controlled Delivery, 23 - 26 Sep 2016, Suzhou, China; Drug Discovery India 2016, 29 - 30 Sep 2016,India; Pharma Expo, 12 - 14 Oct 2016, Saint-Petersburg, Russia;MENA Pharmaceutical Manufacturing Congress,29th nov-1dec,2016,Saudi Arabia; International Pharmaceutical Students' Federation (IPSF); Pharmaceutical Society of Australia; American Society for Pharmacy Law; American Society of Consultant Pharmacists FoundationPharmaceutical Society Of New Zealand

Track 05: Advances in Drug delivery system

The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all. On the other hand, the very slow progress in the efficacy of the treatment of severe diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. From this, new ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, biorecognition, and efficacy of drugs were generated. These new strategies, often called drug delivery systems (DDS), are based on interdisciplinary approaches that combine polymer science, pharmaceutics, bioconjugate chemistry, and molecular biology. For over 20 years, researchers have appreciated the potential benefits of nanotechnology in providing vast improvements in drug delivery and drug targeting. Improving delivery techniques that minimize toxicity and improve efficacy offers great potential benefits to patients, and opens up new markets for pharmaceutical and drug delivery companies. Other approaches to drug delivery are focused on crossing particular physical barriers, such as the blood brain barrier, in order to better target the drug and improve its effectiveness; or on finding alternative and acceptable routes for the delivery of protein drugs other than via the gastro-intestinal tract, where degradation can occur.

Related Conferences

9th World Drug Delivery Summit, June 30-July 02, 2016 New Orleans, Louisiana, USA; 43rd Annual Meeting and Exposition of the Controlled Release Society, July 17-20,2016, Seattle, WA, US; 3rd Annual Controlled & Modified Drug Release, August 30-31,2016, Philadelphia, PA, US ; 2nd Drug Delivery StrategyAdvanced Mechanisms & Product Design, August 30-31,2016, Philadelphia, PA, US ; Transdermal Drug Delivery 2016, September 12-13.,2016, Barcelona, Spain; PDA Universe of Pre-filled Syringes & Injection Devices, October 17-18,2016, Huntington Beach, CA, US; Peptide Drug Design & Delivery Summit, October 25-26,2016, Boston, MA, US; 6th Annual Partnership Opportunities in Drug Delivery (PODD 2016), October 27-28,2016, Boston, MA, US; Extractables & Leachables Europe (E&L Europe 2016), November 8-10,2016, Dublin, Ireland; Respiratory Drug Delivery ASIA 2016 (RDD ASIA 2016), November 9-11,2016, Goa, India; Inhaled Drug Delivery, London, UK; Drug Delivery to the Lungs 27 (DDL27), December 7-9,2016, Edinburgh, UK;7th Annual Global Pharma Summit, August 22-24, 2016 New Orleans, Louisiana, USA; 6th Pharmacovigilance Congress, September 28-30, 2016 Toronto, Canada ; Drug Formulation & Bioavailability Congress , September 05-07, 2016 Beijing, China ;18th International Conference on Pharmaceutical Pre-formulation and Clinical Drug Development, August 4-5th,2016 Vancouver, Canada;  2016  AAPS Annual Meeting and Exposition, November 13–17, 2016, Denver, USA;3rd Annual Formulation & Drug Delivery Congress 2017,May 2017,London,UK;American Society of Health-System Pharmacists (ASHP); National Pharmacy AssociationCanadian Pharmacists AssociationEuropean Pharmaceutical Union (EPU); International Pharmaceutical Students' Federation (IPSF); Pharmaceutical Society of Australia

Track 06Technologies in Drug Delivery

The drug delivery technology landscape is rapidly evolving with new classes of pharmaceuticals and biologics fuelling this revolution. The last few decades have witnessed the emergence of several drug delivery technologies including hydrogels, liposomes, microparticles, nanoparticles, and polymers. The growth of drug delivery solutions is of increasing importance to pharmaceutical companies, and has resulted in significant changes in the drug delivery landscape. The future growth projections for these devices are increasing, causing a number of innovative drug delivery systems to be introduced each year. With significant paradigm shifts in drug discovery and development, the industry is also gearing up to adopt alternative drug delivery strategies in order to further facilitate drug development. Opportunities have significantly increased in the last few years. Pharmaceutical companies are collaborating with drug delivery firms to effectively target patient concerns. Newer methods, such as transdermal technologies, intelligent delivery systems capable of modulated delivery, nasal delivery and skin-based delivery technologies, have come up. And the change in the outlook of the drug delivery industry is further facilitating a better understanding of market dynamics, encouraging innovation for alternative technologies and giving rise to competition

 Related Conference

9th World Drug Delivery Summit, June 30-July 02, 2016 New Orleans, Louisiana, USA; 43rd Annual Meeting and Exposition of the Controlled Release Society, July 17-20,2016, Seattle, WA, US; 3rd Annual Controlled & Modified Drug Release, August 30-31,2016, Philadelphia, PA, US ; 2nd Drug Delivery StrategyAdvanced Mechanisms & Product Design, August 30-31,2016, Philadelphia, PA, US ; Transdermal Drug Delivery 2016, September 12-13.,2016, Barcelona, Spain; PDA Universe of Pre-filled Syringes & Injection Devices, October 17-18,2016, Huntington Beach, CA, US; Peptide Drug Design & Delivery Summit, October 25-26,2016, Boston, MA, US; 6th Annual Partnership Opportunities in Drug Delivery (PODD 2016), October 27-28,2016, Boston, MA, US; Extractables & Leachables Europe (E&L Europe 2016), November 8-10,2016, Dublin, Ireland; Respiratory Drug Delivery ASIA 2016 (RDD ASIA 2016), November 9-11,2016, Goa, India; Inhaled Drug Delivery, London, UK; Drug Delivery to the Lungs 27 (DDL27), December 7-9,2016, Edinburgh, UK;7th Annual Global Pharma Summit, August 22-24, 2016 New Orleans, Louisiana, USA; 6th Pharmacovigilance Congress, September 28-30, 2016 Toronto, Canada ; Drug Formulation & Bioavailability Congress , September 05-07, 2016 Beijing, China ;18th International Conference on Pharmaceutical Pre-formulation and Clinical Drug Development, August 4-5th,2016 Vancouver, Canada;  2016  AAPS Annual Meeting and Exposition, November 13–17, 2016, Denver, USA;3rd Annual Formulation & Drug Delivery Congress 2017,May 2017,London,UK; European Pharmaceutical Union (EPU); International Pharmaceutical Students' Federation (IPSF); Pharmaceutical Society of Australia;  American Society for Pharmacy LawAmerican Society of Consultant Pharmacists Foundation

Track 07: Nanotechnology for Enhancing Bioavailability of Poorly Soluble Drugs

Most of the new chemical entities coming out from High-throughput screening in drug discovery process are failing due to their poor solubility in the water. Poorly water-soluble drugs show many problems in formulating them in conventional dosage forms. One of the critical problems associated with poorly soluble drugs is too low bioavailability. The problem is even more complex for drugs belonging to BCS CLASS II category, as they are poorly soluble in both aqueous and organic media, and for those drugs having a log P value of 2. There are number of formulation approaches to resolve the problems of low solubility and low bioavailability. These techniques for solubility enhancement have some limitations and hence have limited utility in solubility enhancement. Nanotechnology can be used to resolve the problems associated with these conventional approaches for solubility and bioavailability enhancement. Nanotechnology is defined as the science and engineering carried out in the nanoscale that is 10-9 meters. The present article describes the details about nanosuspensions. Nanosuspensions consist of the pure poorly water-soluble drug without any matrix material suspended in dispersion. A nanosuspension not only solves the problems of poor solubility and bioavailability but also alters the pharmacokinetics of drug and thus improves drug safety and efficacy. The conventional dosage forms thus may result in over- or under-medication and poor patient compliance. These challenges can be overcome by applying novel drug delivery systems that offer benefits like reduction in dose frequency, lowering of dose size, site specific targeting, enhanced permeability, and improvement in oral bioavailability. Nanotechnology is a promising strategy in the development of drug delivery systems especially for those potent drugs whose clinical development failed due to their poor solubility, low permeability, inadequate bioavailability, and other poor biopharmaceutical properties. The most common nanotechnology based strategies used in development of delivery systems are nanoemulsions, dendrimers, micelles, liposomes, solid lipid nanoparticles, polymeric nanoparticles, carbon nanotubes, and so forth, which provide controlled, sustained, and targeted drug delivery. The nanotechnology based systems have extensively been investigated for improvement of the bioavailability of antihypertensive drugs

Related Conferences

7th World Nano Conference, June 20-21, 2016, Cape Town, South Africa; 11th International Conference and Expo on Nanoscience and Molecular Nanotechnology, October 20-22, 2016 ROME, ITALY; 10th International Conference on Nanomedicine and Nanotechnology in Health Care, July 25 - 27, 2016, Bangkok Thailand; 11th International Conference and Expo on Nanoscience and Molecular Nanotechnology, Oct 20 - 22, 2016, Rome Italy; The 6th Annual World Congress of Nano Science & Technology – 2016, Oct 26 - 28, 2016, Singapore; IEEE NANO,22-25 Aug,2016; Applied Nanotechnology and Nanoscience International Conference 2016, Nov 09 - 11, 2016, Barcelona Spain; Nanophotonics and Micro/Nano Optics International Conference (NANOP 2016), Dec 7th - Dec 9th,2016,France;3rd International Conference on Nanoscience and Nanotechnology 2016;15th-16th Dec,2016,Colombo,Srilanka; 8th International Conference on Nanomaterials - Research & Application,19th-21st Oct,2016,Czech Republic;  Chinese Pharmaceutical Association; Pakistan Pharmacists Association; International Pharmaceutical Federation (FIP); International Federation of Pharmaceutical Manufacturers and Associations (IFPMA); European Federation of Pharmaceutical Industries and Associations (efpia)

Track 08: Novel Drug Target Approaches

Identifying drug targets plays essential roles in designing new drugs and combating diseases. Unfortunately, our current knowledge about drug targets is far from comprehensive. Screening drug targets in the lab is an expensive and time-consuming procedure. In the past decade, the accumulation of various types of study of science related data makes it possible to develop computational approaches to predict drug targets. Non-communicable diseases such as cancer, atherosclerosis and diabetes are responsible for major social and health burden as millions of people are dying every year. Out of which, atherosclerosis is the leading cause of deaths worldwide. The lipid abnormality is one of the major modifiable risk factors for atherosclerosis. Both genetic and environmental components are associated with the development of atherosclerotic plaques. Immune and inflammatory mediators have a complex role in the initiation and progression of atherosclerosis. Understanding of all these processes will help to invent a range of new biomarkers and novel treatment modalities targeting various cellular events in acute and chronic inflammation that are accountable for atherosclerosis. Several biochemical pathways, receptors and enzymes are involved in the development of atherosclerosis that would be possible targets for improving strategies for disease diagnosis and management.

Related Conferences

5th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery SystemsMarch 16-18, 2016, Crown Plaza, Dubai, UAE; 2nd International Conference on Clinical Trials,22nd-24th Aug,2016,Usa; Africa Pharmaceutical Summit West 2016,6th-7th Sept,2016,Nigeria; Asia Pacific Drug Formulation and Bioavailability Congress,5th-7th Sept, Beijing, China; 14th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics,17th-19th October, Malaysia;    Indian Pharmaceutical Association; American Association of Pharmaceutical Scientists (AAPS); Royal Pharmaceutical Society; American Pharmacists Association (APhA); American Society of Health-System Pharmacists (ASHP)

Track 09: Industrial Pharmacy

Industrial pharmacy is an area of the pharmaceutical field that specialized in creating drugs and medications. Industrial pharmacists use the latest methods, technologies and processes to develop new and groundbreaking medications. They are also responsible for determining if medications developed by pharmaceutical companies have both the right ingredients and the correct amount of these ingredients. It’s a field in which pharmacists can make a real difference in the lives of people who use medications to treat a variety of illnesses and conditions.

Responsibilities and Duties

Industrial pharmacists research drug compounds and develop new medications based on research. They test medications for efficiency and safety, oversee the production process to ensure medications are produced accurately, and they engage marketing and promoting new drugs to consumers, hospitals and doctors' offices. An industrial pharmacist may also be responsible for conducting clinical drug trials and evaluating the results of these trials to gauge a drug’s effectiveness and to determine potential risks or side effects. As part of a drug trial, industrial pharmacists collaborate with other pharmaceutical companies, local and federal governments, and a variety of health care professionals to ensure trials are conducted safety and within federal or state guidelines for drug testing.

Related Conferences

Drug Formulation & Bioavailability Congress, September 05-07, 2016 Beijing, China; RICT 2016 — Interfacing Chemical Biology and Drug Discovery, 06-09 Jul 2016, Caen, France; International Conference and Exhibition on Pharmaceutical Development and Technology, April 24-26, 2017 Dubai, UAE; Asia Pacific Drug Formulation & Bioavailability Congress, September 05-07, 2016, Beijing, China; International Pharmacy Conference, 14th - 15th July 2016, Pennsylvania, USA; 5th Global Pharmacists Annual Meeting, 14th - 16th July 2016, Brisbane, Australia; Asia Pacific Pharma Congress, 14th - 16th July 2016, Kuala Lumpur, Malaysia; 5th Annual European Pharma Congress, 18th - 20th July 2016; 10th International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care, 25th - 27th July 2016, Bangkok, Thailand; II International Conference on Clinical Sciences and Drug Discovery, 27th - 29th July 2016, Scotland, United Kingdom; 3rd Annual Advanced API Convention, 25 Jul 2016 - 27 Jul 2016,India;  CSDD-2016 — II International Conference on Clinical Sciences and Drug Discovery, 27 - 29 Jul 2016, Scotland, United Kingdom; Innovations in Formulation and Drug Delivery 2016, 28 - 29 Jul 2016,India; Drug Discovery & Therapy World Congress 2016 (4th in the Series), 22 Aug 2016 - 25 Aug 2016, MA, United States; 2016 Pharma CI USA Conference & Exhibition, 13-14 Sep 2016, NJ, United States; 4th GPCR in Drug Discovery Conference, 14 - 15 Sep 2016, Boston, United States; DOT — 14th Annual Discovery on Target, 19 - 22 Sep 2016,Boston, MA, United States; 2nd Annual Quality in Pharma & Biotech, 22 - 23 Sep 2016, Vienna, Austria; 4th Symposium on Innovative Polymers for Controlled Delivery, 23 - 26 Sep 2016, Suzhou, China; Drug Discovery India 2016, 29 - 30 Sep 2016,India; Pharma Expo, 12 - 14 Oct 2016, Saint-Petersburg, Russia; MENA Pharmaceutical Manufacturing Congress,29th nov-1dec,2016,Saudi Arabia; International Pharmaceutical Students' Federation (IPSF); Pharmaceutical Society of Australia; American Society for Pharmacy Law; American Society of Consultant Pharmacists FoundationPharmaceutical Society Of New Zealand

Track 10: Pharmaceutical Aerosols

Aerosol means packaging of therapeutic active ingredients in a pressurized system. Aerosols are depends on the power of compressed or liquefied gas to expel the contents from container. There are many advantages with these aerosols like 1.A dose can be removed without contamination material 2. The medication can be delivered directly to the affected area in a desired form such as spray, steam, quick breaking foam or stable foam.3. Irritation produced by the application of topical medication is reduced or eliminated.4. Ease of convenience of application5. Application of medication in thin layer.

Related Conferences

2nd International Conference and Expo on Drug Discovery & Designing, October 27-28, 2016 Rome, Italy; Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, August 29-31, 2016 Atlanta, Georgia, USA; Global Pharmaceutical Industry Summit, 19 - 21 September 2016 / Austria, Vienna; Drug Formulation & Bioavailability Congress, September 05-07, 2016 Beijing, China; International Conference and Exhibition on Pharmaceutical Development and Technology, April 24-26, 2017 Dubai, UAE; Asia Pacific Drug Formulation & Bioavailability Congress, September 05-07, 2016, Beijing, China; International Pharmacy Conference, 14th - 15th July 2016, Pennsylvania, USA; 5th Global Pharmacists Annual Meeting, 14th - 16th July 2016, Brisbane, Australia; Asia Pacific Pharma Congress, 14th - 16th July 2016, Kuala Lumpur, Malaysia; 5th Annual European Pharma Congress, 18th - 20th July 2016; 10th International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care, 25th - 27th July 2016, Bangkok, Thailand; II International Conference on Clinical Sciences and Drug Discovery, 27th - 29th July 2016, Scotland, United Kingdom;American Society for Pharmacy Law;  American Society of Consultant Pharmacists Foundation ;  Pharmaceutical Society Of New Zealand;  Chinese Pharmaceutical AssociationPakistan Pharmacists Association

Track 11: Pharmaceutical Engineering

Pharmaceutical engineering is a branch of pharmaceutical science and technology that involves development and manufacturing of products, processes, and components in the pharmaceuticals industry (i.e. drugs & biologics). While developing pharmaceutical products involves many interrelated disciplines (e.g. medicinal chemists, analytical chemists, clinicians/pharmacologists, pharmacists, chemical engineers, biomedical engineers, etc.), the specific subfield of "pharmaceutical engineering" has only emerged recently as a distinct engineering discipline. This now brings the problem-solving principles and quantitative training of engineering to complement the other scientific fields already involved in drug development.

Related Conferences

2nd International Conference and Expo on Drug Discovery & Designing, October 27-28, 2016 Rome, Italy; Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, August 29-31, 2016 Atlanta, Georgia, USA; Global Pharmaceutical Industry Summit, 19 - 21 September 2016 / Austria, Vienna; Drug Formulation & Bioavailability Congress, September 05-07, 2016 Beijing, China; International Conference and Exhibition on Pharmaceutical Development and Technology, April 24-26, 2017 Dubai, UAE; Asia Pacific Drug Formulation & Bioavailability Congress, September 05-07, 2016, Beijing, China; International Pharmacy Conference, 14th - 15th July 2016, Pennsylvania, USA; 5th Global Pharmacists Annual Meeting, 14th - 16th July 2016, Brisbane, Australia; Asia Pacific Pharma Congress, 14th - 16th July 2016, Kuala Lumpur, Malaysia; 5th Annual European Pharma Congress, 18th - 20th July 2016; 10th International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care, 25th - 27th July 2016, Bangkok, Thailand; II International Conference on Clinical Sciences and Drug Discovery, 27th - 29th July 2016, Scotland, United Kingdom;American Society for Pharmacy Law;  American Society of Consultant Pharmacists Foundation ;  Pharmaceutical Society Of New Zealand;  Chinese Pharmaceutical AssociationPakistan Pharmacists Association

Drug manufacturing (Pharmaceutical Manufacturing)  is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations, such as milling, granulation, coating, tablet pressing, and others. The changing pharmaceutical landscape is a popular discussion point as of late. Armed with a fresh, non-blockbuster-reliant business model and treatment options that are expanding from small molecules to a range of new, more targeted therapies, the industry is at what PwC calls, “a critical juncture.”

Parenteral drug delivery is the second largest segment of this transformative pharmaceutical market  eclipsed only by the more mature oral solid dosage forms  accounting for nearly 30 percent of total pharma market share. According to Survey, the market for parenteral drug delivery products is projected to rise over 10 percent annually to $86.5 billion in 2019.

Related Conference:

QbD in Drug Product Devbelopment AND QbD in API Manufacturing, 11-13 October 2016, Berlin, Germany; Conference on why FDA at my Facility is, and what do I do During an Inspection,June 21 - July 22, 2016; 6th Pharmacovigilance Congress, September 28-30, 2016 Toronto, Ontario, Canada; 5th International Summit on GMP, GCP & Quality Control, August 12-13, 2016 Toronto, Ontario, Canada; 7th International Conference and Exhibition on Pharmacovigilance, August 22-24, 2016 Vienna, Austria; Global Pharmaceutical Industry Summit, August 22-24, 2016,Vienna, Austria; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, August 29-31, 2016 Atlanta, Georgia, USA; International Conference on Pharma Marketing, November 10-11, 2016 Alicante, Spain; International Pharmaceutical Method Development and Validation Conference,  November 24-25, 2016 Dubai, UAE; CLEANING VALIDATION WORKSHOP 2016, June 23-24, 2016; Pharmaceutical Supply Chain Integrity - Good Distribution Practices (GDP),July 4-5, 2016,China; 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2016, 28 August 2016- 01 September 2016,Buenos Aires, Argentina; 1st International conference on risk assessment of pharmaceuticals in the environment, September 2016- 09 September 2016,Paris, France; Pharmacovigilance, 06 -08 Dec 16,USA;International Pharmaceutical Federation (FIP); International Federation of Pharmaceutical Manufacturers and Associations (IFPMA); European Federation of Pharmaceutical Industries and Associations (efpia); Indian Pharmaceutical Association; American Association of Pharmaceutical Scientists (AAPS)

Track 13: Pharmaceutical Technology

The application of scientific knowledge or technology to pharmacy, pharmacology, and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures and in the treatment of patients.

Related Conferences

International Conference and Exhibition on Pharmaceutical Nanotechnology, July 27-29, 2017 Rome, Italy; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 13-15, 2017 London, UK; 18th International Pharmaceutical Technology Symposium (IPTS 2016), 18 -21 September 2016, Antalya, Turkey; International Pharmaceutical Method Development and Validation Conference, November 24-25, 2016 Dubai, UAE; 15th World Medical Nanotechnology Congress & Expo, July 28 - 29,2017 ,Frankfurt, Germany; 2016 CPPR Conference on Freeze Drying of Pharmaceuticals and Biologicals, July 12 - 16, 2016; Scientific Design of Pharmaceutical Formulations, October 3rd and 4th, 2016;Drug Formulation & Bioavailability Congress, September 05-07, 2016 Beijing, China; International Conference and Exhibition on Pharmaceutical Development and Technology, April 24-26, 2017 Dubai, UAE; Asia Pacific Drug Formulation & Bioavailability Congress, September 05-07, 2016, Beijing, China; International Pharmacy Conference, 14th - 15th July 2016, Pennsylvania, USA; 5th Global Pharmacists Annual Meeting, 14th - 16th July 2016, Brisbane, Australia; Asia Pacific Pharma Congress, 14th - 16th July 2016, Kuala Lumpur, Malaysia; 5th Annual European Pharma Congress, 18th - 20th July 2016; 10th International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care, 25th - 27th July 2016, Bangkok, Thailand; II International Conference on Clinical Sciences and Drug Discovery, 27th - 29th July 2016, Scotland, United Kingdom;Scientific Design of Pharmaceutical Formulations, October 3rd and 4th, 2016; Royal Pharmaceutical SocietyAmerican Pharmacists Association (APhA); American Society of Health-System Pharmacists (ASHP); National Pharmacy AssociationCanadian Pharmacists Association

Track 14: Recent Advances in Medical Devices

The role of medical devices in health care is essential. A medical device is an instrument, apparatus, implant, in vitro reagent, or similar that is used to diagnose, prevent, or treat disease or other conditions. This category includes news on product recalls, product safety, implants and prosthetics, new technological developments, robotic surgery, medical devices for use by medical professionals or patients. Medical devices and medical electronics are areas that had little to offer 100 years ago. However, there were three important existing technologies that led to many further developments over the following 100 years. These are the stethoscope, electrocardiography, and X-ray medical imaging. Although these technologies had been described and were available to some extent when the Proceedings  of the IEEE pages first appeared, they had yet to achieve the widespread use that they have today.

Related Conferences

Middle East Surgical and Medical Devices Expo, October 10-12, 2016 Dubai, UAE; Medical Devices Summit 2016,15th-16th Sept,2016,Sandiego; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 13-15, 2017 London, UK; Training — Controlled Drugs: Safe Use, Prescribing and Management, 30th September, United Kingdom; iSMIT/DMD-EU 2016 — 28th international conference of the  international Society for Medical Innovation and Technology (iSMIT), 05 - 08 Oct 2016, Delft, Netherlands; 7th World Congress on Healthcare & Technologies, September 26-27, 2016 London, UK; 4th International Conference on Medical Informatics and Health, October 06-07, 2016 London, UK; 9th Nano Congress for Next Generation, August 1-2, 2016 Manchester, United Kingdom; National Pharmacy AssociationCanadian Pharmacists Association;  European Pharmaceutical Union (EPU); International Pharmaceutical Students' Federation (IPSF); Pharmaceutical Society of Australia

Track 15: Regulatory Requirements for Pharmaceuticals

The regulatory requirements of various countries of the world vary from each other. Therefore, it is challenging for the companies to develop a single drug which can be simultaneously submitted in all the countries for approval. The regulatory strategy for product development is essentially to be established before commencement of developmental work in order to avoid major surprises after submission of the application. The role of the regulatory authorities is to ensure the quality, safety, and efficacy of all medicines in circulation in their country. It not only includes the process of regulating and monitoring the drugs but also the process of manufacturing, distribution, and promotion of it. One of the primary challenges for regulatory authority is to ensure that the pharmaceutical products are developed as per the regulatory requirement of that country. This process involves the assessment of critical parameters during product development.

The pharmaceutical industry is one of the highly regulated industries, with many rules and regulations enforced by the government to protect the health and well-being of the public. Therefore, the aim of the pharmaceutical industry is to identify and develop a generic drug product which can be tailor made to meet the diverse market requirements. As per global market trend, it is estimated that approximately $150 billion worth of drugs will be off-patented during the period 2010 to 2017, which will serve as a platform for pharmaceutical companies to develop generic drugs. 

Related Conference

6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR, Sept 29- Sept 30, 2016  Orlando, USA; Seminar on Validation and 21 CFR 11 Compliance of Computer Systems: Intermediate to Advanced, July 14-15, 2016; 2nd International Symposium on Scientific and Regulatory Advances in Complex Drugs (SRACD 2016), 10 October 2016- 11 October 2016, Budapest, Hungary;9th Annual Pharmaceutical Regulatory Affairs Asia, 2-5 Auguat,2016; International Conference and Exhibition on Pharmaceutical Development and Technology, April 24-26, 2017 Dubai, UAE; 7th Annual Global Pharma Summit, August 22-24, 2016 New Orleans, Louisiana, USA; 6th Pharmacovigilance Congress, September 28-30, 2016 Toronto, Canada ; Drug Formulation & Bioavailability Congress , September 05-07, 2016 Beijing, China ;18th International Conference on Pharmaceutical Pre-formulation and Clinical Drug Development, August 4-5th,2016 Vancouver, Canada;  2016  AAPS Annual Meeting and Exposition, November 13–17, 2016, Denver, USA;European Federation of Pharmaceutical Industries and Associations (efpia); Indian Pharmaceutical Association; American Association of Pharmaceutical Scientists (AAPS); Royal Pharmaceutical Society; American Pharmacists Association (APhA)

Track 16: Methodological  Advancements in Pharmaceutical Industries

As developers and manufacturers of life-saving products, the world’s leading pharmaceutical companies play an important role in improving access to medicine for the world’s poor. Through their own initiatives and in collaboration with other relevant stakeholders such as multi-lateral organizations, governments and the global health community, these companies are increasingly helping to address the access to medicine challenge. In order to suitably capture the industry’s progress in line with society’s evolving expectations, the Access to Medicine Index methodology is systematically reviewed every two years. While maintaining as much consistency as possible for the purpose of trend analysis, the methodology is adjusted where needed. 

Related Conferences

Drug Formulation & Bioavailability Congress, September 05-07, 2016 Beijing, China; RICT 2016 — Interfacing Chemical Biology and Drug Discovery, 06-09 Jul 2016, Caen, France; International Conference and Exhibition on Pharmaceutical Development and Technology, April 24-26, 2017 Dubai, UAE; Asia Pacific Drug Formulation & Bioavailability Congress, September 05-07, 2016, Beijing, China; International Pharmacy Conference, 14th - 15th July 2016, Pennsylvania, USA; 5th Global Pharmacists Annual Meeting, 14th - 16th July 2016, Brisbane, Australia; Asia Pacific Pharma Congress, 14th - 16th July 2016, Kuala Lumpur, Malaysia; 5th Annual European Pharma Congress, 18th - 20th July 2016; 10th International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care, 25th - 27th July 2016, Bangkok, Thailand; II International Conference on Clinical Sciences and Drug Discovery, 27th - 29th July 2016, Scotland, United Kingdom; 3rd Annual Advanced API Convention, 25 Jul 2016 - 27 Jul 2016,India;  CSDD-2016 — II International Conference on Clinical Sciences and Drug Discovery, 27 - 29 Jul 2016, Scotland, United Kingdom; Innovations in Formulation and Drug Delivery 2016, 28 - 29 Jul 2016,India; Drug Discovery & Therapy World Congress 2016 (4th in the Series), 22 Aug 2016 - 25 Aug 2016, MA, United States; 2016 Pharma CI USA Conference & Exhibition, 13-14 Sep 2016, NJ, United States; 4th GPCR in Drug Discovery Conference, 14 - 15 Sep 2016, Boston, United States; DOT — 14th Annual Discovery on Target, 19 - 22 Sep 2016,Boston, MA, United States; 2nd Annual Quality in Pharma & Biotech, 22 - 23 Sep 2016, Vienna, Austria; 4th Symposium on Innovative Polymers for Controlled Delivery, 23 - 26 Sep 2016, Suzhou, China; Drug Discovery India 2016, 29 - 30 Sep 2016,India; Pharma Expo, 12 - 14 Oct 2016, Saint-Petersburg, Russia; MENA Pharmaceutical Manufacturing Congress,29th nov-1dec,2016,Saudi Arabia; National Pharmacy Association;  Canadian Pharmacists Association;  European Pharmaceutical Union (EPU); International Pharmaceutical Students' Federation (IPSF); Pharmaceutical Society of Australia

About Conference

ConferenceSeries LLC is a renowned organization that organizes highly notable pharmaceutical conferences and healthcare conferences throughout the globe. Conferenceseries LLC invites all the participants from all over the world to attend International Conference and Exhibition on Pharmaceutical Development and Technology during April 24-26, 2016 in Dubai, UAE.Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

 Pharma Tech 2017 is a latest technological platform to aid efficient drug discovery and development. These platforms range from vast chemical libraries, ultra-high throughput screening and huge genetic databases in discovery, to predictive toxicology platforms and even deep-seated knowledge of particular therapeutic areas in development. New research platforms designed to help its teams of investigators focus on a set of key strategic initiatives that will help guide their multibillion-dollar drug development program to advance new medicines that can get ahead of a disease and prevent it from taking a toll. 

Pharmaceutical technology is a collective term for technologies to develop candidate compounds that have either been discovered or created into commercial pharmaceutical products. These products are made by transforming chemical compounds with useful effects on the human body into high-quality dosage forms that can appropriately exhibit effects against disease. Pharmaceutical technologies are divided into the following three functions.

Process technology for researching synthetic methods to be used to manufacture candidate compounds efficiently and consistently in large amounts and with high quality. Formulation technology for investigating dosage forms, formulations, and packages based on absorption stability, and usability in consideration of the characteristics of candidate compounds, and then selecting and preparing the optimal administration form. Analytical and quality evaluation technology for establishing a variety of analytical and quality evaluation systems to properly and appropriately assure the quality of the pharmaceutical products.

Efficacy and safety are the primary requirements for any pharmaceutical product. However, it is becoming significantly more important to provide pharmaceutical products that can be more easily used by patients, healthcare professionals, and caregivers in order to respond to the rapid aging of society and the needs for advanced medical care. Examples of user-friendly pharmaceutical products include extended-release tablets, which reduce the frequency at which pharmaceuticals must be administrated, and orally disintegrating (OD) tablets, which can be taken without water. Meanwhile, examples of innovation for healthcare professionals include syringes that are prefilled with drug solutions to reduce the hassle of preparation and the risk of needle injuries, as well as IC tags for pharmaceutical products or packages that are helpful in preventing medical errors. Additionally, we are utilizing various formulation technologies to provide user-friendly pharmaceutical products adding new value. Such innovations on this front include package designs and tablets with the product name printed on them in order to prevent any misuse.

We are advancing the development of new synthetic processes based on the eco-friendly concept of “green chemistry,” which is aimed at achieving global environmental sustainability through means such as preventing pollution and reducing consumption of materials and energy.

Why to attend???        

With members from around the world focused on learning about innovations, latest technologies, different drug formulations for effective treatment  and new drug moieties through pharmaceutical technology  and its importance, this is your best opportunity to reach the largest assemblage of participants from the Clinical Research organizations, Pharmaceutical companies and technology related societies  Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new research developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent issues, approaches, and the novel trends in Pharmaceutical Technology are hallmarks of this conference

Major sessions included at this conference are Pre-formulation studies, Drug Formulation Procedures, Drug Product Manufacturing, Pharmaceutical Engineering, Pharmaceutical Manufacturing, Pharmaceutical Technology, Technologies in Drug Delivery, Types of Pharmaceutical Formulations, Regulatory Requirements for Pharmaceuticals, Thermodynamics, Pharmaceutical Management.

.

Market Analysis

Scope and Importance:

Pharmaceutical Technology is a latest technological platform to aid efficient drug discovery and development. These platforms range from vast chemical libraries, ultra-high throughput screening and huge genetic databases in discovery, to predictive toxicology platforms and even deep-seated knowledge of particular therapeutic areas in development. New research platforms designed to help its teams of investigators focus on a set of key strategic initiatives that will help guide their multibillion-dollar drug development program to advance new medicines that can get ahead of a disease and prevent it from taking a toll .Pharmaceutical research indulges in making medicines from plant- and chemical-based compounds. They work to prevent the spread of disease, ease pain, cure illnesses, and slow the effects of aging, among many other things. Pharmaceutical companies' mission to discover the next ground breaking medicine is a big cause steeped in big bucks, big competition, and, at times, big controversy. Insiders refer to the handful of multinational giants that dominate the industry-Pfizer and GlaxoSmithKline, to name two of the largest-as Big Pharma.

About Venue:

Dubai is the most populous city in the United Arab Emirates (UAE). It is located on the southeast coast of the Persian Gulf and is one of the seven emirates that make up the country. The city of Dubai is located on the emirate’s northern coastline and heads up the Dubai-Sharjah-Ajman metropolitan area.Dubai is to host World Expo 2020.

Dubai has emerged as a global city and business hub of the Middle East. It is also a major transport hub for passengers and cargo. By the 1960s, Dubai’s economy was based on revenues from trade and, to a smaller extent, oil exploration concessions, but oil was not discovered until 1966. Oil revenue first started to flow in 1969. Dubai’s oil revenue helped accelerate the early development of the city, but its reserves are limited and production levels are low: today, less than 5% of the emirate’s revenue comes from oil. The emirate’s Western-style model of business drives its economy with the main revenues now coming from tourism, aviation, real estate, and financial services. Dubai has recently attracted world attention through many innovative large construction projects and sports events. The city has become iconic for its skyscrapers and high-rise buildings, in particular the world’s tallest building, the Burj Khalifa.

Dubai provides a world class education and also enormous job opportunities. The most well-known universities in Dubai are American University in Dubai, Hult International Business School, Al Ghurair University, The American College of Dubai, University of Wollongong in Dubai, British University in Dubai offering courses in Business Administration, Engineering, Architecture and Interior Design.

American University in Dubai is one of the six UAE universities featured in QS World University Rankings 2014/2015. In 2013 Synergy University Dubai Campus opened its campus in Jumeirah Lakes Towers being a first University in Dubai to located outside of Educational Zones.

 Pharmaceutical Technologies and Markets:

Overall sales in the Pharmaceutical market amounted to $34.2 billionin 2007, and decreased slightly to $31.1 billion in 2009. By 2014, they are projected to reach $32.2 billion, for a 5-year compound annual growth rate (CAGR) of 0.7%.

The largest segment of the market, prescription drugs, was valued at $27.4 billion in 2008; this is expected to decrease to $26,3 billion in 2009, and to reach $27 billion in 2014, for a 5-year CAGR of 0.5%.The global excipients market was at $4.6 billion in 2010 and it is expected to reach at $4.9 billion in 2011. It is further anticipated to increase to $6.7 billion by 2016 at a compound annual growth rate (CAGR) of 6.5%.

 

Societies in United Arab Emirates:

Saudi Pharmaceutical Society or Kuwait Pharmaceutical Association.

Societies and Associations in Asia:

Federation of Asian Pharmaceutical Associations (FAPA)

Asia Partnership Conference of Pharmaceutical Associations(APAC)

  Societies World Wide:

   Association de Pharmacie Galénique Industrielle (APGI)

    Controlled Release Society (CRS)

    Institute of Pharmacy Management International (IPMI)

    International Academy of Compounding Pharmacists (IACP)

    International Association for Pharmaceutical Technology (APV)

    International eHealth Association

    International Federation of Pharmaceutical Manufacturers Associations (IFPMA)

    International Federation of Pharmaceutical Wholesalers (IFPW)

    International Pharmaceutical Excipients Council (IPEC)

    International Pharmaceutical Federation (FIP)

    International Pharmaceutical Students Federation (IPSF)

    International Society for Medical Publication Professionals (ISMPP)

    International Society of Oncology Pharmacy Practitioners (ISOPP)

    International Society for Pharmaceutical Engineering (ISPE)

    International Society for Pharmacoepidemiology (ISPE)

    International Society for the History of Pharmacy (ISHP)

    International Society for the Study of Xenobiotics (ISSX)

    International Society of Pharmaceutical Compounding (ISPhC)

    International Young Pharmacists' Group (YPG)

    Parenteral Drug Association (PDA)

    Regulatory Affairs Professionals Society (RAPS)

    Society for Biomolecular Sciences (SBA)

    Society for Cell Science (SFCS)

    Society for Translational Oncology (STO)

Pharmaceutical Universities UAE:                                                                        

           

Affiliated institution

School Location

 

Ref

 

 

DubaiPharmacy College

Muhaisnah

Ajman University of Science and Technology

Faculty of Pharmacy and Health Sciences

Ajman, Fujairah          

University of Sharjah

College of Pharmacy

University City of Sharjah           

RAK Medical and Health Sciences University

College of Pharmaceutical Sciences

Ras al Khaimah          

 

Gulf Medical University       

College of Pharmacy

Ajman 

 

Al Ain University of Science and Technology

Faculty of Pharmacy and Health Sciences

Al Ain 

 

 

 

Pharmaceutical Industries in United Arab Emirates:

Pfizer UAE

Johnson & Johnson Middle East

Merck UAE    

Novo Nordisk Pharma Gulf

Gulf Pharmaceutical Industry-Julphar (JULPHAR)    

Smart Health and Nutrition Ltd.

Hikma Pharmaceuticals PLC   

Valeant Pharmaceuticals MEA FZ LLC

Al-Hayat Pharmaceuticals       

Amgen

Elis Pharmaceuticals Limited  

Alliance Global

Sanofi Aventis UAE   

Genpharm

Ranbaxy Laboratories Limited

BioPharma

GlaxoSmithKline        

Gulf Inject

Saga Pharmaceuticals  

Global Pharma

Astra Zeneca UAE      

Neopharma

Baxter A.G     

Medpharma

 

 

 

 

Past Conference Report

Pharmaceutica 2016

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Pharmaceutica 2016 Conference the best ever!

The 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, hosted by the Conferenceseries LLC was held during March 07-09, 2016 at Melia Avenida America, Madrid, Spain based on the theme Challenges and Advances in Novel Drug Delivery Systems". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Pharmaceutics and Drug Delivery Systems, who made this event a grand success.

Conferenceseries LLC expresses its gratitude to the conference Moderator, namely Dr. Volkmar Weissig for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

Similarly we also extend our appreciation towards our Poster judges namely, Dr. Volkmar Weissig, Dr. Amiram Goldblum, and Dr. B B Barik.

A very special Thanks to our Exhibitors and Sponsors to have bestowed and their faith and invested in us to make this event a fruitful one. We hope you continue your support in our future endeavours.  

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Pre-formulation Considerations
  • Formulation Aspects for Various Routes
  • Recent Advances in Drug Delivery Technology
  • Drug Targeting
  • Nanotechnology in Drug Delivery Systems
  • Application of Nanotechnology
  • Major Challenges in Drug Delivery System
  • Physiological Considerations
  • Vaccine Drug Delivery Systems
  • Biotherapeutics-Drug Discovery and Development
  • Medical Devices for Drug Delivery
  • Smart Drug Delivery Systems
  • Delivery Methods for Peptides and Biologics
  • Global Drug Policy in Drug Delivery Technology
  • Entrepreneurs Investment Meet

Conferenceseries LLC offers its heartfelt appreciation to organizations such as CiMUSUniversity of Santiago de CompostelaMinistry of Health, KSA and our esteemed Media Partners (NIAFIPPharmaVisionBRECBentham ScienceThe Pharma Review), and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. Conference Series LLC also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Exhibitors who supported this event.

With the grand success of Pharmaceutica 2016Conference Series LLC is proud to announce the "10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems" to be held during March 13-15, 2017 at London, UK.

Best Poster Awards:

  • David Veale, Reckitt Benckiser Health Care Ltd., UK
  • Nataliya Storozhylova, University of Santiago de Compostela, Spain
  • Shayan F Lahiji, Yonsei University, Republic of South Korea
  • Anton Aleksashkin, Lomonosov Moscow State University, Russia
  • Abdulaziz Al Mahallawi, Cairo University, Egypt
  • Mohamed Yehia Abouleish, American University of Sharjah, UAE
  • Ahlam Zaid Alkilani, Al-Zaytoonah University of Jordan, Jordan

For More details visit: http://novel-drugdelivery-systems.pharmaceuticalconferences.com/

 

Past Reports  Proceedings  Gallery  

Pharma Middle East 2015

Our heartfelt thanks to all of our wonderful and renowned speakers, conference attendees, students, associations and guests for making Pharma Middle East 2015 an indelible event and a mile stone.

Pharma Middle East-2015 was hosted by Conferenceseries LLC hosted which was scheduled during November 02-04, 2015 at Al Ghuriar Rayhaan by Rotana, Dubai, UAE with the theme “Conscientious awareness of Pharmacists & Pharmaceutical sciences”.

The response to Pharma Middle East 2015 was huge and was attended by more than 100 attendees from different corners of the world.

The conference was initiated with the Honorable presence of the Keynote forum. The list includes:

  • Anthony Serracino-Inglott, University of Malta, Malta
  • Mohamad T Khayyal, Cairo University, Egypt
  • V Ravi Chandran, Life Enhancing Technologies LLC., USA
  • Pardeep K Gupta, University of the Sciences in Philadelphia, USA
  • Yousef A Alomi, Ministry of Health, KSA
  • Sridevi Chigurupati, Asian Institute of Medicine, Science & Technology, Malaysia

We thank our keynote speakers for finding time in their busy schedules to join us and share their inspiring and thought provoking perspectives. We specially thank Lilian M Azzopardi, University of Malta, Malta for her support as a moderator for the conference. We also thank V Ravi Chandran, Life Enhancing Technologies LLC., USA and Derar Omari, Yarmouk University, Jordan for their continous support for success of the conference.

The conference had several workshops, multiple diversified sessions, panel discussions, B2B meetings and Poster sessions. We received active participation from various Professors, Pharma Companies, Researchers, students and leaders from the fields of Pharmacy and Health Care Business and Research Professionals, who made this event a Grand Success. The high quality of the presentations are to be commended; it is clearly a reflection of the skills, expertise and passion that abounds in the Scientific Research.

All accepted abstracts have been indexed in Conferenceseries LLC Journal of Clinical Pharmacology and Biopharmaceutics as a special issue.

Conferenceseries LLC  offers its heartfelt appreciation to organizations such as University of Malta, Cairo University, Egyptian Society of Pharmacology and Experimental Therapeutics and esteemed organizations, obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Conferenceseries LLC  also took privilege to felicitate the Organizing Committee Members, Editorial Board Members and Media Partners who supported this event.

Various sessions were carried out with multiple presentations from speakers all around the world. Major Sessions discussed were:

  • Pharmacological Sciences
  • Bio-Pharmaceutical Sciences
  • Pharmaceutical Chemistry and Medicinal Chemistry
  • Pharmacognosy and Phytochemistry
  • Nanotechnology
  • Drugs and Regulations
  • Industrial Pharmacy and Pharmacy Practice
  • Genetics, Genetic Engineering and Biomedical Engineering
  • Ethics in Pharmacy
  • Pre formulation Study &Techniques
  • Green Chemistry in Pharmaceutical Industry
  • Clinical Pharmacy and Pharmacotherapeutics
  • Pharmaceutical Microbiology and Biotechnology
  • Pharmaceutical Business and Market
     

Conferenceseries LLC offers its heartfelt appreciation to all the members who supported us throughout the event. Also, it would be incomplete without thanking all our expert presenters from all around the world which includes various outside experts, company representatives and other eminent personalities who supported the conference by fecilitating the discussion forums. We believe that the knowledge you have shared will help immensely in the development of the Pharmaceutical research and eventually translate into better programs.

With the grand success of  Pharma Middle East 2015Conferenceseries LLC is proud to announce the “8thAnnual Pharma Middle East Congress" going to be held during October 10-12, 2016 at Dubai, UAE.

2016 Highlights:

  • 300+ Participation (70% Industry and 30% Academia)
  • 7+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 13 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

For More details visit: http://middleeast.pharmaceuticalconferences.com/


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date April 24-26, 2017

For Sponsors & Exhibitors

Sponsorship Opportunities

Speaker Opportunity

Day 1 Day 2 Day 3

Supported By

Pharmaceutica Analytica Acta Drug Designing: Open Access International Journal of Pharma Research & Review

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner